Clinical Trial Update: Study of MEDI 507 in the Treatment of Pediatric Patients [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial of MEDI-507 in pediatric patients with graft-versus-host disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• MEDI-507

Snippet

Sponsor: MedImmune LLC | Conditions: Graft Versus Host Disease | Phase 1 | Status: COMPLETED